Responsible for management of all legal matters. Member of senior management team. Duties include: attendance and preparation of minutes for Board and Committee meetings; preparation, review and negotiation of all agreements, including DNA service agreements, license agreements and employment-related agreements; review of all responses to RFPs for provision of services to government agencies; participation on pricing committee for pricing of services; enforcement of contract policies for Company; preparation of all SEC filings, including Form 10-Q, Form 10-K and Proxy Statement; management of and coordination with outside counsel; managing litigation matters; review of patent filings; due diligence on all proposed acquisitions; and review of all public disclosures materials.

Responsible for management of all legal matters. Member of senior management team. Duties include: attendance and preparation of minutes for Board and Committee meetings; preparation, review and negotiation of all agreements, including licenses, marketing, manufacturing and supply agreements, financing documents and employment-related agreements; institution and enforcement of contract and research grant policies for Company; review of all marketing materials and responsibility for compliance with related laws and regulations; preparation of all SEC filings, including Form 10-Q, Form 10-K and Proxy Statement; management of and coordination with outside counsel; managing litigation matters; review of all patent filings; due diligence on all proposed licenses and acquisitions; and review of all public disclosures and marketing materials.Representative transactions:License Agreement with The Dow Chemical Company;Manufacturing and Supply Agreement with Laureate Pharma;License Agreement with Savient Pharmaceuticals;Manufacturing Agreement with Rosemont Pharmaceuticals;License Agreement with Seattle Genetics;License and Acquisition Agreements with Progenics;License, supply and distribution agreements with Cardinal Health.

Managed multi-million dollar corporate practice serving technology clients. Acted as outside general counsel for a number of public and private companies guiding Board members on fiduciary duties as well as Sarbanes-Oxley issues, and managing all aspects of legal work, including litigation, real estate and employment law. Counseled management of companies on legal and business issues associated with transactions. Responsible for preparing and reviewing SEC reports for a number of public clients. Managed licensing practice serving technology clients. Firm responsibilities include Opinion Committee (review of opinions for corporate transactions) and Associates Committee (semi-annual review of associate performance throughout firm).Representative transactions:CollaGenex Pharmaceuticals, Inc. – equity financings and numerous supply, licensing and distribution agreements;Cytogen Corporation – equity financing transactions and supply and licensing transactions;Bio-Imaging Technologies, Inc. – PIPE transaction and acquisitions;Voxware, Inc. – preferred stock financings;Linguagen Corporation – numerous licensing agreements;DSET Corporation – sale of company;Aptegrity, Inc. – sale of company;QSS, Inc. – sale of company; andCommTech Corporation – sale of company.

Developed and managed multi-million dollar corporate practice serving technology clients. Acted as outside general counsel for a number of public and private companies. Responsible for advising Board members on legal and business issues, preparing and reviewing SEC reports, and managing IPOs, acquisitions, venture capital investments in private clients and bank financings. Built licensing practice serving technology clients dealing with supply, distribution, research and licensing transactions.Representative transactions:ECCS, Inc. – IPO and several preferred stock financings;Advanced Surgical, Inc. – IPO and licensing transactions;Prophet 21, Inc. – IPO;Intelligroup, Inc. – IPO and spin-off of internet business;DSET Corporation - IPO and several acquisitions;Sensar, Inc. – several preferred stock financings, numerous licensing transactions, and sale of company; andUnidigital, Inc. – numerous acquisitions and loan transactions.